Investment objective

To provide long-term capital growth by investing in equity securities of European companies in order to provide exposure to growth opportunities in the European economy and diversification benefits beyond North America.

Download fund details    Download fund commentary   

Fund details

Series

Currency

Fund code

MER * (%)

F CAD 35075 0.99%

Portfolio analysis As of Apr 30, 2026

100% 0 %
Equity Fixed Income

Asset mix

Equity Sector Allocation

Financials24.7%
Industrials19.6%
Health Care12.1%
Utilities7.8%
Materials7.6%
Consumer Staples7.5%
Information Technology7.4%
Energy6.3%
Consumer Discretionary4.2%
Communication Services2.8%

Top 10 Holdings

% Assets

ASML Holding NV 4.6%
HSBC Holdings PLC 2.9%
Iberdrola SA 2.8%
AstraZeneca PLC 2.8%
Novartis AG 2.7%
Roche Holding AG 2.7%
Allianz SE 2.5%
TotalEnergies SE 1.9%
Schneider Electric SE 1.8%
Nestle SA 1.8%
Total % of Top 10 Holdings 26.5%

Geographic allocation

Region

Performance analysis

Growth of $10,000 since inception

Calendar returns

Trailing return

Empty column 1 Mth 3 Mth 6 Mth 1 year 3 years 5 years 10 years Since Inception Empty column
3.6 -1.6 4.9 16.3 10.4 7.8 8.0 5.2 Fund

Distribution ($)/unit

Empty column YTD* 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Total distributions 0.00 3.71 1.12 1.00 0.46 1.62 0.41 0.48 1.09 1.20 0.59
Interest --- 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 --- ---
Canadian dividends --- --- --- --- --- --- --- --- --- --- ---
Foreign dividends --- 0.45 0.56 0.59 0.43 0.34 0.30 0.51 0.55 0.39 0.34
Foreign taxes paid --- -0.04 -0.07 -0.06 -0.04 -0.03 -0.03 -0.04 -0.06 -0.04 -0.03
Capital gains --- 3.30 0.63 0.46 0.06 1.30 0.14 --- 0.60 0.85 0.28
Return of capital --- --- --- --- --- --- --- --- --- --- ---

* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.